United States Platelet Rich Plasma(PRP) Market Research: Market Segmentation By PRP Type, By Origin, By Application & by Region with Forecast 2017-2030

United States Platelet Rich Plasma (PRP) Market Overview

Platelet Rich Plasma therapy (PRP) is the non-invasive treatment to treat long lasting musculoskeletal conditions by natural healing. As per American society of plastic surgeons, around 18.1 million cosmetic procedures are done in the U.S. in 2017. Stop Sports Injuries report stated that there are around 2.45 million sports injuries takes place in high school athletes and more than 3.78 million kids under 14 years receive treatment for sports injury in the U.S. in 2017. In general, PRP is not considered a first line treatment and is usually considered after other more traditional treatments have failed.

United States platelet rich plasma market is poised to grow at a CAGR of 5.5% (2017-2030). Increasing scenarios of chronic tendon injuries, acute ligament and muscle injuries, surgery, knee arthritis and fractures are boosting prospects for the market. Rotator cuff injuries, lumbar spine disc pain, shoulder pain and instability, tennis and golfer’s elbow in the athletes are effectively treated. However, exponentially high costs for cosmetic treatments and lack of proper reimbursement policies could hamper the platelet rich plasma market’s trajectory.

United States Platelet Rich Plasma Market Segmentation

By PRP Type

• Pure-PRP
• Leucocyte Rich PRP
• Pure Platelet Rich Fibrin
• Leukocyte-Rich PRF

Leukocyte-rich PRP is the fastest growing segment, on the account of presence of inductive properties that encourage healing, reduce inflammation and the most favorable methods for the treatment of soft tissue defects.

By Origin

• Autologous
• Homologus
• Allogeneic

By Application

• Orthopedics
• Cosmetic Surgery and Dermatology
• Neurosurgery
• General Surgery
• Cardiothoracic Surgery
• Urology
• Ophthalmology

Orthopedics accounted for 35.1% of total market share in 2017 as PRP injections aid in rapid augmentation of soft tissue healing process while cosmetic surgery and dermatology application are the fastest growing segments. 

Covered In This United States Platelet Rich Plasma Market Report        

The report covers the present ground scenario and the future growth prospects of the facility management market for 2017-2030 along with the market players’ analysis. We calculated the market size and revenue share on the basis of revenue generated from major players worldwide. Platelet Rich Plasma market is forecasted on the basis of revenue analysis, product benchmarking and strategic developments of key market players.

United States Platelet Rich Plasma Market Outlook 2017-2030, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the Platelet Rich Plasma market space. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. “United States Platelet Rich Plasma Market Report” also recognizes value chain analysis to understand the cost differentiation, pricing models to provide competitive advantage to the existing and new entry players.

Key Market Players

Our United States Platelet Rich Plasma Market Report comprises of the following companies as the key players:

• T-Biotechnology (T-LAB)
• Arthrex Inc.
• Terumo BCT Inc.
• EmCyte Corporation
• DePuy Synthes
• Zimmer Biomet
• Stryker
• Glofinn Oy
• DR. PRP AMERICA
• LLC
• Harvest Technologies Corporation
• Arteriocyte Medical systems
• Regen Lab Sa
• Exactech Inc.
• Cesca Therapeutics Inc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For a full detailed overview, send us the sample request.

Key questions answered in this United States Platelet Rich Plasma Market Report

• What is the total market size by 2030 and what would be the expected growth rate of market?
• What is the total revenue per segment and region in 2016-17 and what would be the expected revenue per segment and region over the forecast period?
• What are the key market trends?
• What are the factors which are driving this market?
• What are the major barriers to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities for the existing and entry level players?
• What are the recent developments and business strategy of the key players?

Reasons to buy this market study

• Facilitate decision-making based on strong historic and forecast data for Platelet Rich Plasma Market
• Develop strategies based on the latest regulatory framework
• Position yourself to gain the maximum advantage of the Healthcare industry’s growth potential
• Identify key partners and business development avenues across the globe
• Respond to your competitors’ business structure, strategy and prospects
• Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
• Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Platelet Rich Plasma Market
• Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
• To strategically profile key players and comprehensively analyze their market shares and core competencies